Endocrine Society Hires Meyers as Chief Strategy Officer

SteveMeyersEndocrineSociety

The Endocrine Society has hired Steven R. Meyers, PhD — an association executive with more than a decade of experience in strategic thinking and transforming and expanding operations — to serve as its chief strategy officer.
 

“I’m an engineer at heart and am energized by challenges that open doors for me to think creatively and shape innovative solutions,” Meyers says. “The Society is committed to evolving its strategic direction and identifying and pursuing new opportunities and I’m thrilled to be joining.”

As chief strategy officer, Meyers will oversee the alignment of the Society’s strategic planning and governance process to include shaping new initiatives and evolving the Society’s strategic plan in collaboration with governance leaders. He will also analyze market dynamics and customer trends to build new business models and enhance existing ones.

Meyers will oversee the executive office and governance team to ensure effective support of the Society’s governance members. He is scheduled to start his new role on September 26.

Meyers most recently served as the senior director, membership at the American Chemical Society, where he served in multiple roles for 11 years.  He previously worked as a contractor for the National Science Foundation and co-founded a company where he invented and developed biosensors to enable at-home diagnostic testing of human breast milk.

“The Endocrine Society is rich in innovative ideas and we’ve set our sights on many exciting opportunities,” says Endocrine Society CEO Kate Fryer. “Throughout his career, Steven has proven to be a strategic architect that can build and implement the vision and models necessary to turn innovative ideas into operational success, and I’m excited to have him join us.”

Meyers earned his PhD in biomedical engineering from Boston University and his BS in biomedical engineering and BA in computer science from Duke University.

You may also like

  • Endocrine Society Celebrates Special Diabetes Program Extension

    The Endocrine Society applauds Congress for approving the first funding increase for the Special Diabetes Program in two decades. The U.S. Senate voted Friday March 8 to extend the program, which supports both diabetes care and research into type 1 diabetes, until the end of 2024. This is part of the six-bill package funding several…

  • New Position Statement Focuses on Patient Experience in Diabetes Care

    Healthcare providers who treat diabetes need to think beyond the clinical numbers, such as solely focusing on a person’s glucose goals. Taking the patient experience into account can improve the quality of care and facilitate attainment of treatment goals, according to a new position statement published in the Endocrine Society’s Journal of Clinical Endocrinology &…

Find more in